Category: 桑拿

Wandong Medical (600055) Annual Report Comments: Core Breeds Achieved Steady Growth in Performance

Wandong Medical (600055) Annual Report Comments: Core Breeds Achieved Steady Growth in Performance The performance is in line with expectations, optimistic that 19 will gradually and steadily grow. The company released its 2018 annual report and 2019 first quarter report on April 26, and achieved operating income of 9 in 2018. 5.5 billion (+7. 98%),[…]

Wandong Medical (600055) Annual Report Comments: Core Breeds Achieved Steady Growth in Performance Continue Reading

Hikvision (002415): The low point of the economic cycle has passed the company’s internal strength

Hikvision (002415): The low point of the economic cycle has passed the company’s internal strength Event: Hikvision released 2018 annual report and 2019 first quarter report: 2018 achieved revenue of 498. 37 ppm, an increase of 18 years. 93%; net profit attributable to mother 113. 53 ppm, an increase of 20 in ten years. 64%.[…]

Hikvision (002415): The low point of the economic cycle has passed the company’s internal strength Continue Reading

Starnet Ruijie (002396): Net profit continuous growth and development is more promising

Starnet Ruijie (002396): Net profit continuous growth and development is more promising Event: On October 30th, Ruijie released the third quarter report, and the company’s revenue in the first three quarters was 59. 930,000 yuan (at least -3. 11%), net profit attributable to mother 4. 80 ppm (ten years +19. 35%), deducting non-attributed net profit4.[…]

Starnet Ruijie (002396): Net profit continuous growth and development is more promising Continue Reading

Hengrui Medicine (600276): The strategic significance of introducing new phase III azole antifungal drugs is far-reaching

Hengrui Medicine (600276): The strategic significance of introducing new phase III azole antifungal drugs is far-reaching Introduced the first new phase III clinical drug overseas. Recently, the company issued an announcement and reached an agreement with Mycovia in the United States to transform the company to treat and prevent infections of a variety of complications,[…]

Hengrui Medicine (600276): The strategic significance of introducing new phase III azole antifungal drugs is far-reaching Continue Reading

Jiayuan Technology (688388): Technology-leading ultra-thin lithium battery copper faucet

Jiayuan Technology (688388): Technology-leading ultra-thin lithium battery copper faucet Investment Highlights: The company is the second largest lithium copper foil manufacturer in China. The company’s main business is the application of lithium ion battery negative current collectors. Research, production and sales of 12μm high-performance electrolytic copper foil and electrolytic copper foil for PCB. The company[…]

Jiayuan Technology (688388): Technology-leading ultra-thin lithium battery copper faucet Continue Reading

Shengda Mining (000603): Silver Leading Reserve Continues to Advance

Shengda Mining (000603): Silver Leading Reserve Continues to Advance Event: Recently, Shengda Mining released its 2019 Interim Report, and the company achieved operating income in the first half of 201911.5.7 billion, an increase of 30 every year.88%; net profit attributable to shareholders of the parent company2.12 ‰, an increase of 9 per year.03%; realized basic[…]

Shengda Mining (000603): Silver Leading Reserve Continues to Advance Continue Reading